Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Fuji
Queensland Health
Fish and Richardson
Mallinckrodt
Chinese Patent Office
Farmers Insurance
Healthtrust
Moodys
Harvard Business School

Generated: August 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204945

« Back to Dashboard
NDA 204945 describes TROSPIUM CHLORIDE, which is a drug marketed by Apotex, Upsher-smith Labs, Heritage Pharms Inc, Paddock Llc, Glenmark Generics, Invagen Pharms, and Actavis Labs Fl Inc, and is included in eight NDAs. It is available from ten suppliers. Additional details are available on the TROSPIUM CHLORIDE profile page.

The generic ingredient in TROSPIUM CHLORIDE is trospium chloride. There are sixteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the trospium chloride profile page.

Summary for NDA: 204945

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Genitourinary Agents

Pharmacology for NDA: 204945

Suppliers and Packaging for NDA: 204945

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TROSPIUM CHLORIDE
trospium chloride
TABLET;ORAL 204945 ANDA Heritage Pharmaceuticals Inc. 23155-530 23155-530-02 200 TABLET, FILM COATED in 1 BOTTLE (23155-530-02)
TROSPIUM CHLORIDE
trospium chloride
TABLET;ORAL 204945 ANDA Heritage Pharmaceuticals Inc. 23155-530 23155-530-05 500 TABLET, FILM COATED in 1 BOTTLE (23155-530-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Aug 30, 2016TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
McKesson
Fish and Richardson
Moodys
Chinese Patent Office
Baxter
Cantor Fitzgerald
Cipla
Covington
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot